{"transactions":[{"id":2007017,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Restricted Stock Units","published_at":"2023-02-17T16:12:48.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":2285714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026."}],"balance_after":2285714,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2285714},"source":{"system":"sec-edgar","filing":"0001062993-23-004040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299323004040/form4.xml","form_type":"4"}},{"id":2047336,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Class A Common Stock","published_at":"2023-01-24T16:07:33.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":19540,"price":1.13,"value":22080.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4."}],"balance_after":29960,"source":{"system":"sec-edgar","filing":"0001062993-23-001325","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299323001325/form4.xml","form_type":"4"}},{"id":2052183,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Restricted Stock Units","published_at":"2023-01-18T17:03:10.000Z","date":"2023-01-14","kind":"exercise","acquired":false,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025."}],"balance_after":100500,"derivative":{"underlying":"Common Stock","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001062993-23-001038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299323001038/form4.xml","form_type":"4"}},{"id":2052182,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Common Stock","published_at":"2023-01-18T17:03:10.000Z","date":"2023-01-14","kind":"exercise","acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49500,"source":{"system":"sec-edgar","filing":"0001062993-23-001038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299323001038/form4.xml","form_type":"4"}},{"id":2384994,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Restricted Stock Units","published_at":"2022-02-18T16:41:25.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001062993-22-004978","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299322004978/form4.xml","form_type":"4"}},{"id":2384993,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T16:41:25.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":118170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option shall vest on January 14, 2023 and an additional 2.0833 and 1/3% of the shares shall vest on the last day of each calendar month thereafter."}],"balance_after":118170,"derivative":{"exercise_price":4.06,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":118170},"source":{"system":"sec-edgar","filing":"0001062993-22-004978","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299322004978/form4.xml","form_type":"4"}},{"id":2481981,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T17:24:03.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":228224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 155,000 shares of common stock of Private Pear for $1.89 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter."}],"balance_after":228224,"derivative":{"exercise_price":1.29,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":228224},"source":{"system":"sec-edgar","filing":"0001062993-21-012391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299321012391/form4.xml","form_type":"4"}},{"id":2481980,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T17:24:03.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":242948,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 165,000 shares of common stock of Private Pear for $1.60 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter."}],"balance_after":242948,"derivative":{"exercise_price":1.09,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":242948},"source":{"system":"sec-edgar","filing":"0001062993-21-012391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299321012391/form4.xml","form_type":"4"}},{"id":2481979,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T17:24:03.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":103068,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.58 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter."}],"balance_after":103068,"derivative":{"exercise_price":1.08,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":103068},"source":{"system":"sec-edgar","filing":"0001062993-21-012391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299321012391/form4.xml","form_type":"4"}},{"id":2481978,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T17:24:03.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":51533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 35,000 shares of common stock of Private Pear for $1.05 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter."}],"balance_after":51533,"derivative":{"exercise_price":0.72,"expiration_date":"2028-03-21","underlying":"Common Stock","underlying_shares":51533},"source":{"system":"sec-edgar","filing":"0001062993-21-012391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299321012391/form4.xml","form_type":"4"}},{"id":2481977,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, COO, Treas., & Asst. Sec."}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T17:24:03.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":478533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in accordance with the terms of the Business Combination Agreement (the \"Business Combination Agreement\") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) (\"Private Pear\"), in exchange for an option to acquire 325,000 shares of common stock of Private Pear for $1.00 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vested or shall vest on December 7, 2018 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter."}],"balance_after":478533,"derivative":{"exercise_price":0.68,"expiration_date":"2027-12-13","underlying":"Common Stock","underlying_shares":478533},"source":{"system":"sec-edgar","filing":"0001062993-21-012391","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219021/000106299321012391/form4.xml","form_type":"4"}},{"id":4495059,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-09T22:13:48.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 6, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019."}],"balance_after":150000,"derivative":{"exercise_price":0.82,"expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-002978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117002978/doc4.xml","form_type":"4"}},{"id":4495058,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-09T22:13:48.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 6, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 1, 2017."}],"balance_after":150000,"derivative":{"exercise_price":0.82,"expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-002978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117002978/doc4.xml","form_type":"4"}},{"id":4498285,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":116731,"kind":"person","name":"GUIFFRE CHRISTOPHERD T","position":1,"cik":"0001219021","reported_name":"GUIFFRE CHRISTOPHERD T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-05T21:21:36.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":5733,"price":0.6,"value":3439.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Cerulean Pharma Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":12489,"source":{"system":"sec-edgar","filing":"0001209191-17-002068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117002068/doc4.xml","form_type":"4"}}]}